What is Zacks Research’s Estimate for ACHC FY2024 Earnings?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Investment analysts at Zacks Research lifted their FY2024 earnings per share estimates for shares of Acadia Healthcare in a report issued on Wednesday, December 18th. Zacks Research analyst Z. Masood now forecasts that the company will post earnings of $3.39 per share for the year, up from their prior estimate of $3.37. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.73 EPS, Q1 2025 earnings at $0.77 EPS and Q4 2025 earnings at $0.99 EPS.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same quarter in the prior year, the company posted $0.91 earnings per share. Acadia Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis.

ACHC has been the subject of a number of other reports. Barclays reduced their price target on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their target price for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Royal Bank of Canada dropped their price target on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research report on Monday, November 18th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Finally, StockNews.com raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday, December 19th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $75.44.

Acadia Healthcare Stock Up 0.5 %

ACHC stock opened at $37.67 on Monday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The company’s 50-day moving average price is $43.03 and its 200 day moving average price is $60.27. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77. The company has a market cap of $3.50 billion, a P/E ratio of 12.35, a P/E/G ratio of 1.77 and a beta of 1.30.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. GAMMA Investing LLC grew its holdings in Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares during the period. Commonwealth Equity Services LLC grew its position in Acadia Healthcare by 3.5% during the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock valued at $513,000 after acquiring an additional 257 shares during the period. Atria Investments Inc raised its holdings in Acadia Healthcare by 4.7% in the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after buying an additional 308 shares during the period. KBC Group NV lifted its position in Acadia Healthcare by 14.4% during the third quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after buying an additional 338 shares in the last quarter. Finally, Tidal Investments LLC grew its stake in Acadia Healthcare by 7.9% during the third quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock worth $296,000 after buying an additional 340 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.